Twist Bioscience Corp (TWST) Stock Price, Quote & News

Company Profile

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing,...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 800 719 0671

Website: www.twistbioscience.com

Address:

681 Gateway Boulevard, South San Francisco, United States

MoneyGroupLLC Sep. 13 at 7:07 PM

Enter: $TWST OCT 17 2025 $28 CALLS Buy in Price: $1.99 - $4.00 Take Profit: $2.23 Stop Bleeding: $1.75 ROI Potential: 12% Exit Within: 61 Minutes https://moneygroup.us/alerts

0 · Reply

GoParabolic Sep. 11 at 9:17 AM

$TWST Cathie Wood’s TWST purchase wasn’t random... there’s definitely a strategic reason behind it. She’s known for spotting innovative companies with strong growth potential, often investing in cutting-edge tech or biotech firms that could reshape industries. When she buys, it usually signals confidence in the company’s long-term prospects. $TSLA $ORCL $AAPL $NVDA

0 · Reply

GoParabolic Sep. 10 at 8:10 PM

$TWST is oversold... $TSLA $AMZN $AAPL $NVDA

1 · Reply

kindness123 Sep. 10 at 2:10 AM

$TWST $TEM $PRME

0 · Reply

NVDAMillionaire Sep. 8 at 4:57 PM

$TWST Brilliant piece that captures TWST's situation perfectly. So if you want to update your understanding of TWST or get to know TWST better, this is essential reading. https://beyondspx.com/quote/TWST/analysis/twist-bioscience-engineering-a-profitable-future-on-silicon-twst

0 · Reply

BioTechHealthX Sep. 7 at 4:49 PM

$TWST With projected FY2026 revenue of $437.9M, Twist Bioscience is scaling fast in synthetic DNA, driving a 21% YOY growth outlook. https://biotechhealthx.com/biotech-news/twist-bioscience-twst-eyes-46-upside-with-40-analyst-target/

1 · Reply

Night_Owl_Biotech Sep. 7 at 2:18 PM

The attachment lists the change in share price for all comm'l-stage oncology (over $100MM market cap) & non-oncology (over $1B market cap) focused bios since Friday 8/22/2025. By 8/22/2025 virtually all bios in these peer groups had reported Q2 2025 sales & results of operations. The XBI is up just over 5% over the last 3 weeks (or 87% annualized). About 2 of every 3 bios in both peer groups are up which means 1 of every 3 are down. This is not investment advice but is it possible some of those who are down, excluding those like $SPRY with news, are oversold. Of course we could be wrong. $AUTL $TWST $VCEL $HRMY

2 · Reply

friendlyinvestor Sep. 1 at 9:00 PM

$TWST anyone with a bull case theory?

2 · Reply

Thelonius_Stonk Aug. 28 at 11:58 AM

$TWST havent been watching because has traded like garbage for so long. however, i think the r/r is good here in the longterm vs ~25 if you like the company @HodlMaBeer

1 · Reply

Estimize Aug. 26 at 10:00 AM

Wall St is expecting -0.40 EPS for $TWST Q4 [Reporting 11/24 BMO] http://www.estimize.com/intro/twst?chart=historical&metric_name=eps&utm_c

0 · Reply

Twist Bioscience to Present at Baird 2025 Global Healthcare Conference

Sep 2, 2025, 8:00 AM EDT - 12 days ago

Twist Bioscience Collaborates with Synthetic Design Lab

Aug 28, 2025, 6:20 AM EDT - 17 days ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR GRAL ILMN IONS MRNA

Aug 19, 2025, 8:00 AM EDT - 26 days ago

Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution

Aug 12, 2025, 10:56 PM EDT - 4 weeks ago

Twist Bioscience: Headwinds Are Mounting

Aug 6, 2025, 8:00 AM EDT - 5 weeks ago

Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors

Aug 4, 2025, 3:52 PM EDT - 5 weeks ago

Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings

Aug 4, 2025, 11:06 AM EDT - 5 weeks ago

Twist Bioscience Corporation (TWST) Q3 2025 Earnings Call Transcript

Aug 4, 2025, 7:15 AM EDT - 5 weeks ago

Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results

Jul 31, 2025, 8:00 AM EDT - 6 weeks ago

Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model

Jul 24, 2025, 8:00 AM EDT - 7 weeks ago

Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Jul 15, 2025, 4:02 PM EDT - 2 months ago

Twist Bioscience: Still Not There Yet

Jul 14, 2025, 8:00 AM EDT - 2 months ago

Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025

Jul 7, 2025, 8:00 AM EDT - 2 months ago

Twist Bioscience Expands Express Delivery Turnaround Time to All Gene Fragments Regardless of Format

May 22, 2025, 8:00 AM EDT - 4 months ago

Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions

May 15, 2025, 8:00 AM EDT - 4 months ago

Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference

May 8, 2025, 8:00 AM EDT - 4 months ago

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

DNA

May 7, 2025, 2:18 AM EDT - 4 months ago

Twist Bioscience: Expansion Efforts Continue To Face Challenges

May 5, 2025, 11:41 AM EDT - 4 months ago

Twist Bioscience Corporation (TWST) Q2 2025 Earnings Call Transcript

May 5, 2025, 7:15 AM EDT - 4 months ago

Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results

May 5, 2025, 7:10 AM EDT - 4 months ago

Twist Bioscience Spins Out DNA Data Storage as Independent Company

May 1, 2025, 12:05 PM EDT - 4 months ago

Twist Bioscience Q2 Earnings Preview: Innovative Products, Not Enough Buyers

Apr 24, 2025, 8:00 AM EDT - 5 months ago

Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System

Mar 31, 2025, 8:00 AM EDT - 5 months ago

Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics

Mar 11, 2025, 7:30 AM EDT - 6 months ago

Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost

Feb 25, 2025, 8:00 AM EST - 7 months ago

Twist Bioscience to Present at Upcoming Investor Conferences

Feb 19, 2025, 8:00 AM EST - 7 months ago

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Feb 5, 2025, 11:30 PM EST - 7 months ago

Twist Bioscience: Valuation Is Weighing On The Stock

Feb 3, 2025, 10:55 AM EST - 7 months ago

Twist Bioscience Corporation (TWST) Q1 2025 Earnings Call Transcript

Feb 3, 2025, 7:15 AM EST - 7 months ago

Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results

Jan 23, 2025, 10:35 AM EST - 8 months ago

Gene Synthesis Market Size to Surpass USD 9.54 Billion by 2033 | Straits Research

Jan 22, 2025, 8:00 AM EST - 8 months ago

Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025

Dec 19, 2024, 8:00 AM EST - 9 months ago

Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference

Nov 29, 2024, 9:55 AM EST - 10 months ago

Twist Bioscience: Path To Profitability Beginning To Take Shape

Nov 18, 2024, 3:16 PM EST - 10 months ago

Twist Bioscience: A Post-Earnings Assessment

Nov 18, 2024, 12:17 PM EST - 10 months ago

Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps

Nov 18, 2024, 11:31 AM EST - 10 months ago

Twist Bioscience Corporation (TWST) Q4 2024 Earnings Call Transcript

Nov 18, 2024, 7:15 AM EST - 10 months ago

Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results

Nov 14, 2024, 8:00 AM EST - 10 months ago

Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference

Nov 8, 2024, 5:14 AM EST - 11 months ago

Twist Bioscience's Earnings Preview: Partnerships And Valuation Make It A 'Buy'

Oct 30, 2024, 8:00 AM EDT - 11 months ago

Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics

Oct 24, 2024, 8:00 AM EDT - 11 months ago

Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024

Oct 22, 2024, 8:00 AM EDT - 11 months ago

Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash

XOMA

Oct 15, 2024, 8:00 AM EDT - 11 months ago

Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer

Sep 12, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance

Sep 9, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels

Aug 27, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience to Present at Baird Global Healthcare Conference 2024

Aug 8, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb

Aug 5, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis

Aug 4, 2024, 8:50 AM EDT - 1 year ago

Twist Bioscience: Lowered Biopharma Expectations Amid Financial Strain (Rating Downgrade)

MoneyGroupLLC Sep. 13 at 7:07 PM

Enter: $TWST OCT 17 2025 $28 CALLS Buy in Price: $1.99 - $4.00 Take Profit: $2.23 Stop Bleeding: $1.75 ROI Potential: 12% Exit Within: 61 Minutes https://moneygroup.us/alerts

0 · Reply

GoParabolic Sep. 11 at 9:17 AM

0 · Reply

GoParabolic Sep. 10 at 8:10 PM

$TWST is oversold... $TSLA $AMZN $AAPL $NVDA

1 · Reply

kindness123 Sep. 10 at 2:10 AM

$TWST $TEM $PRME

0 · Reply

NVDAMillionaire Sep. 8 at 4:57 PM

0 · Reply

BioTechHealthX Sep. 7 at 4:49 PM

1 · Reply

Night_Owl_Biotech Sep. 7 at 2:18 PM

2 · Reply

friendlyinvestor Sep. 1 at 9:00 PM

$TWST anyone with a bull case theory?

2 · Reply

Thelonius_Stonk Aug. 28 at 11:58 AM

$TWST havent been watching because has traded like garbage for so long. however, i think the r/r is good here in the longterm vs ~25 if you like the company @HodlMaBeer

1 · Reply

Estimize Aug. 26 at 10:00 AM

Wall St is expecting -0.40 EPS for $TWST Q4 [Reporting 11/24 BMO] http://www.estimize.com/intro/twst?chart=historical&metric_name=eps&utm_c

0 · Reply

RemitTekram Aug. 22 at 7:22 PM

$TWST ....

0 · Reply

regiarc Aug. 8 at 10:06 AM

$TWST bottom is in

3 · Reply

bettingonbiotech Aug. 7 at 4:04 PM

$TWST oversold yet? Or are we going down to low 20's?

0 · Reply

Shawzzzzzz Aug. 6 at 12:09 AM

$TWST Cathie is buying more

1 · Reply

WantedToRetireEarly Aug. 5 at 11:06 AM

$TWST $DNA a solid quarter from TWST with revenues growing and margins improving. EBITDA loss of only 8m. On track for breaeven in 2026. Synbio revenues were down https://finance.yahoo.com/news/twist-bioscience-corp-twst-q3-070852613.html

1 · Reply

stockman899 Aug. 5 at 5:31 AM

$TWST Beats top and bottom and now sitting on support. Easy buy for long term portfolio

0 · Reply

LewisDaKat Aug. 4 at 9:55 PM

News Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results https://marketwirenews.com/news-releases/twist-bioscience-announces-fiscal-2025-third-quarter-7841277323140800.html $TWST

0 · Reply

The300 Aug. 4 at 6:48 PM

$TWST is winning the race to the bottom…. if you want a company selling a commodity there are plenty of profitable businesses to choose from

0 · Reply

bettingonbiotech Aug. 4 at 6:47 PM

$TWST not great, need clinical diagnostics not agbio

0 · Reply

Okadarlan Aug. 4 at 5:18 PM

$TWST told you so...

0 · Reply

RemitTekram Aug. 4 at 5:12 PM

$TWST Gee.... Who could of guessed this was BS. Glad I loaded at the bottom today!!

0 · Reply

LadsAndGents Aug. 4 at 3:13 PM

$TWST but why

0 · Reply

Market Cap	1.53B
Revenue (ttm)	312.97M
Net Income (ttm)	-208.73M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-66.69%
Debt to Equity Ratio	0.03

Volume	1,503,400
Avg Vol	1,472,906
Day's Range	N/A - N/A
Shares Out	60.36M
Stochastic %K	39%
Beta	2.31
Analysts	Strong Sell
Price Target	$40.89